Save the Date for the Second Annual Boston Society Medical Symposium on Acute Myeloid Leukemia (AML)
October 4, 2019

Broad Institute of MIT and Harvard 
415 Main Street 
Cambridge, MA 02142

Invited Speakers 


Daniel J. DeAngelo, MD, PhD, Associate Professor, Medicine, Harvard Medical School

Current Landscape for the Treatment of Patients with Acute Myloid  Leukeia



Terry Fry, MD, Professor of Pediatrics, Hematology and Immunology, Children's Hospital Colorado

Immunotherapies for AML - title TBA


Jacqueline S. Garcia, MD, Physician, DFCI, Instructor in Medicine, Harvard Medical School

Defining a Role for BH3 Mimetics in High Risk Myeloid Malignancies


Julie-Aurore Losman, MD, PhD, Assistant Professor, DFCI and Harvard Medical School

Title TBA



Gwen Nichols, MD, Chief Medical Officer, The Leuklemia & Lymphoma Society

LLS Children's Innitiative



Recent Drug Approvals in Acute Myeloid Leukemia


David Sallman, MD, Department of Malignant Hematology, Moffitt Cancer Center 

Title TBA


Kimberly Stegmaier MD, Professor of Pediatrics, Harvard Medical School, Ted Williams Investigator, Dana-Farber Cancer Institute 

Pediatric AML-title TBA


Patrick Zweidler-McKay, MD, PhD, Medical Director for Hematologic Malignancies, ImmunoGen

Title TBA


 AML 2019 Sessions 

Session I:  The Current Landscape - Updates

Session II:  State of the Art Research and Treatment Options - Updates

Session III:  On the Horizon



 Join our Linkedin Group:


Session I:  The Current Landscape - Updates

Session II:  Session II - State of the Art Research and Treatment Updates

Session III:  On the Horizon


Click here to register for the AML 2019 conference online.

AML 2019 will take place

October 4, 2019

Broad Institute

Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy